(NASDAQ: BRKR) Bruker's forecast annual revenue growth rate of 2.74% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.22%.
Bruker's revenue in 2025 is $3,442,800,000.On average, 16 Wall Street analysts forecast BRKR's revenue for 2025 to be $532,534,971,150, with the lowest BRKR revenue forecast at $506,439,240,370, and the highest BRKR revenue forecast at $552,258,488,600. On average, 16 Wall Street analysts forecast BRKR's revenue for 2026 to be $539,665,781,305, with the lowest BRKR revenue forecast at $506,439,240,370, and the highest BRKR revenue forecast at $565,913,231,450.
In 2027, BRKR is forecast to generate $570,919,970,495 in revenue, with the lowest revenue forecast at $524,645,564,170 and the highest revenue forecast at $614,918,586,345.